Loading…

The Diabetic Cardiac Fibroblast: Mechanisms Underlying Phenotype and Function

Diabetic cardiomyopathy involves remodeling of the heart in response to diabetes that includes microvascular damage, cardiomyocyte hypertrophy, and cardiac fibrosis. Cardiac fibrosis is a major contributor to diastolic dysfunction that can ultimately result in heart failure with preserved ejection f...

Full description

Saved in:

Bibliographic Details
Published in:	International journal of molecular sciences 2020-02, Vol.21 (3), p.970
Main Authors:	Levick, Scott P, Widiapradja, Alexander
Format:	Article
Language:	English
Subjects:	Cardiomyocytes Cardiomyopathy Cardiovascular disease Collagen Congestive heart failure Coronary vessels Cyclin-dependent kinases Diabetes Diabetes mellitus diabetic cardiomyopathy Extracellular matrix Fibroblasts Fibrosis Genotype & phenotype Glucose heart Heart failure Heart surgery high glucose Hypertrophy Kinases Microvasculature Phenotypes Review Rodents
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by	cdi_FETCH-LOGICAL-c478t-4306a3918b1f1059f3bab7cc4b4acc106309ea3a5664a0aa189a58ebc34f97853
cites	cdi_FETCH-LOGICAL-c478t-4306a3918b1f1059f3bab7cc4b4acc106309ea3a5664a0aa189a58ebc34f97853
container_end_page
container_issue	3
container_start_page	970
container_title	International journal of molecular sciences
container_volume	21
creator	Levick, Scott P Widiapradja, Alexander
description	Diabetic cardiomyopathy involves remodeling of the heart in response to diabetes that includes microvascular damage, cardiomyocyte hypertrophy, and cardiac fibrosis. Cardiac fibrosis is a major contributor to diastolic dysfunction that can ultimately result in heart failure with preserved ejection fraction. Cardiac fibroblasts are the final effector cell in the process of cardiac fibrosis. This review article aims to describe the cardiac fibroblast phenotype in response to high-glucose conditions that mimic the diabetic state, as well as to explain the pathways underlying this phenotype. As such, this review focuses on studies conducted on isolated cardiac fibroblasts. We also describe molecules that appear to oppose the pro-fibrotic actions of high glucose on cardiac fibroblasts. This represents a major gap in knowledge in the field that needs to be addressed.
doi_str_mv	10.3390/ijms21030970
format	article
fullrecord	<record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_99021d534a864b54b02fa43155210ce9</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_99021d534a864b54b02fa43155210ce9</doaj_id><sourcerecordid>2352048553</sourcerecordid><originalsourceid>FETCH-LOGICAL-c478t-4306a3918b1f1059f3bab7cc4b4acc106309ea3a5664a0aa189a58ebc34f97853</originalsourceid><addsrcrecordid>eNpdkU1v1DAURS0EoqWwY40isWHRgeevxGZRCU0ZqNQKFu3aenacGY8Se7ATpPn3pEyppqxs2UdH775LyFsKHznX8Clsh8IocNANPCOnVDC2AKib50f3E_KqlC0A40zql-SEM2ACpDglN7cbX10GtH4MrlpibgO6ahVsTrbHMn6ubrzbYAxlKNVdbH3u9yGuq58bH9O43_kKY1utpujGkOJr8qLDvvg3D-cZuVt9vV1-X1z_-Ha1_HK9cKJR40JwqJFrqiztKEjdcYu2cU5Ygc5RqOcwHjnKuhYIiFRplMpbx0WnGyX5Gbk6eNuEW7PLYcC8NwmD-fuQ8tpgngP13mgNjLaSC1S1sFJYYB0KTqWcl-a8nl0XB9dusoNvnY9jxv6J9OlPDBuzTr9NA7zWUs2CDw-CnH5NvoxmCMX5vsfo01QM45KBUFLyGX3_H7pNU47zqgyTQtWNFs39ROcHyuVUSvbd4zAUzH3n5rjzGX93HOAR_lcy_wNBA6ZS</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2548679479</pqid></control><display><type>article</type><title>The Diabetic Cardiac Fibroblast: Mechanisms Underlying Phenotype and Function</title><source>PubMed Central Free</source><source>Publicly Available Content Database</source><creator>Levick, Scott P ; Widiapradja, Alexander</creator><creatorcontrib>Levick, Scott P ; Widiapradja, Alexander</creatorcontrib><description>Diabetic cardiomyopathy involves remodeling of the heart in response to diabetes that includes microvascular damage, cardiomyocyte hypertrophy, and cardiac fibrosis. Cardiac fibrosis is a major contributor to diastolic dysfunction that can ultimately result in heart failure with preserved ejection fraction. Cardiac fibroblasts are the final effector cell in the process of cardiac fibrosis. This review article aims to describe the cardiac fibroblast phenotype in response to high-glucose conditions that mimic the diabetic state, as well as to explain the pathways underlying this phenotype. As such, this review focuses on studies conducted on isolated cardiac fibroblasts. We also describe molecules that appear to oppose the pro-fibrotic actions of high glucose on cardiac fibroblasts. This represents a major gap in knowledge in the field that needs to be addressed.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms21030970</identifier><identifier>PMID: 32024054</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Cardiomyocytes ; Cardiomyopathy ; Cardiovascular disease ; Collagen ; Congestive heart failure ; Coronary vessels ; Cyclin-dependent kinases ; Diabetes ; Diabetes mellitus ; diabetic cardiomyopathy ; Extracellular matrix ; Fibroblasts ; Fibrosis ; Genotype & phenotype ; Glucose ; heart ; Heart failure ; Heart surgery ; high glucose ; Hypertrophy ; Kinases ; Microvasculature ; Phenotypes ; Review ; Rodents</subject><ispartof>International journal of molecular sciences, 2020-02, Vol.21 (3), p.970</ispartof><rights>2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c478t-4306a3918b1f1059f3bab7cc4b4acc106309ea3a5664a0aa189a58ebc34f97853</citedby><cites>FETCH-LOGICAL-c478t-4306a3918b1f1059f3bab7cc4b4acc106309ea3a5664a0aa189a58ebc34f97853</cites><orcidid>0000-0001-5034-4942</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2548679479/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2548679479?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32024054$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Levick, Scott P</creatorcontrib><creatorcontrib>Widiapradja, Alexander</creatorcontrib><title>The Diabetic Cardiac Fibroblast: Mechanisms Underlying Phenotype and Function</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Diabetic cardiomyopathy involves remodeling of the heart in response to diabetes that includes microvascular damage, cardiomyocyte hypertrophy, and cardiac fibrosis. Cardiac fibrosis is a major contributor to diastolic dysfunction that can ultimately result in heart failure with preserved ejection fraction. Cardiac fibroblasts are the final effector cell in the process of cardiac fibrosis. This review article aims to describe the cardiac fibroblast phenotype in response to high-glucose conditions that mimic the diabetic state, as well as to explain the pathways underlying this phenotype. As such, this review focuses on studies conducted on isolated cardiac fibroblasts. We also describe molecules that appear to oppose the pro-fibrotic actions of high glucose on cardiac fibroblasts. This represents a major gap in knowledge in the field that needs to be addressed.</description><subject>Cardiomyocytes</subject><subject>Cardiomyopathy</subject><subject>Cardiovascular disease</subject><subject>Collagen</subject><subject>Congestive heart failure</subject><subject>Coronary vessels</subject><subject>Cyclin-dependent kinases</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>diabetic cardiomyopathy</subject><subject>Extracellular matrix</subject><subject>Fibroblasts</subject><subject>Fibrosis</subject><subject>Genotype & phenotype</subject><subject>Glucose</subject><subject>heart</subject><subject>Heart failure</subject><subject>Heart surgery</subject><subject>high glucose</subject><subject>Hypertrophy</subject><subject>Kinases</subject><subject>Microvasculature</subject><subject>Phenotypes</subject><subject>Review</subject><subject>Rodents</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkU1v1DAURS0EoqWwY40isWHRgeevxGZRCU0ZqNQKFu3aenacGY8Se7ATpPn3pEyppqxs2UdH775LyFsKHznX8Clsh8IocNANPCOnVDC2AKib50f3E_KqlC0A40zql-SEM2ACpDglN7cbX10GtH4MrlpibgO6ahVsTrbHMn6ubrzbYAxlKNVdbH3u9yGuq58bH9O43_kKY1utpujGkOJr8qLDvvg3D-cZuVt9vV1-X1z_-Ha1_HK9cKJR40JwqJFrqiztKEjdcYu2cU5Ygc5RqOcwHjnKuhYIiFRplMpbx0WnGyX5Gbk6eNuEW7PLYcC8NwmD-fuQ8tpgngP13mgNjLaSC1S1sFJYYB0KTqWcl-a8nl0XB9dusoNvnY9jxv6J9OlPDBuzTr9NA7zWUs2CDw-CnH5NvoxmCMX5vsfo01QM45KBUFLyGX3_H7pNU47zqgyTQtWNFs39ROcHyuVUSvbd4zAUzH3n5rjzGX93HOAR_lcy_wNBA6ZS</recordid><startdate>20200201</startdate><enddate>20200201</enddate><creator>Levick, Scott P</creator><creator>Widiapradja, Alexander</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-5034-4942</orcidid></search><sort><creationdate>20200201</creationdate><title>The Diabetic Cardiac Fibroblast: Mechanisms Underlying Phenotype and Function</title><author>Levick, Scott P ; Widiapradja, Alexander</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c478t-4306a3918b1f1059f3bab7cc4b4acc106309ea3a5664a0aa189a58ebc34f97853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Cardiomyocytes</topic><topic>Cardiomyopathy</topic><topic>Cardiovascular disease</topic><topic>Collagen</topic><topic>Congestive heart failure</topic><topic>Coronary vessels</topic><topic>Cyclin-dependent kinases</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>diabetic cardiomyopathy</topic><topic>Extracellular matrix</topic><topic>Fibroblasts</topic><topic>Fibrosis</topic><topic>Genotype & phenotype</topic><topic>Glucose</topic><topic>heart</topic><topic>Heart failure</topic><topic>Heart surgery</topic><topic>high glucose</topic><topic>Hypertrophy</topic><topic>Kinases</topic><topic>Microvasculature</topic><topic>Phenotypes</topic><topic>Review</topic><topic>Rodents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Levick, Scott P</creatorcontrib><creatorcontrib>Widiapradja, Alexander</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Levick, Scott P</au><au>Widiapradja, Alexander</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Diabetic Cardiac Fibroblast: Mechanisms Underlying Phenotype and Function</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2020-02-01</date><risdate>2020</risdate><volume>21</volume><issue>3</issue><spage>970</spage><pages>970-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Diabetic cardiomyopathy involves remodeling of the heart in response to diabetes that includes microvascular damage, cardiomyocyte hypertrophy, and cardiac fibrosis. Cardiac fibrosis is a major contributor to diastolic dysfunction that can ultimately result in heart failure with preserved ejection fraction. Cardiac fibroblasts are the final effector cell in the process of cardiac fibrosis. This review article aims to describe the cardiac fibroblast phenotype in response to high-glucose conditions that mimic the diabetic state, as well as to explain the pathways underlying this phenotype. As such, this review focuses on studies conducted on isolated cardiac fibroblasts. We also describe molecules that appear to oppose the pro-fibrotic actions of high glucose on cardiac fibroblasts. This represents a major gap in knowledge in the field that needs to be addressed.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>32024054</pmid><doi>10.3390/ijms21030970</doi><orcidid>https://orcid.org/0000-0001-5034-4942</orcidid><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 1422-0067
ispartof	International journal of molecular sciences, 2020-02, Vol.21 (3), p.970
issn	1422-0067 1661-6596 1422-0067
language	eng
recordid	cdi_doaj_primary_oai_doaj_org_article_99021d534a864b54b02fa43155210ce9
source	PubMed Central Free; Publicly Available Content Database
subjects	Cardiomyocytes Cardiomyopathy Cardiovascular disease Collagen Congestive heart failure Coronary vessels Cyclin-dependent kinases Diabetes Diabetes mellitus diabetic cardiomyopathy Extracellular matrix Fibroblasts Fibrosis Genotype & phenotype Glucose heart Heart failure Heart surgery high glucose Hypertrophy Kinases Microvasculature Phenotypes Review Rodents
title	The Diabetic Cardiac Fibroblast: Mechanisms Underlying Phenotype and Function
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T05%3A10%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Diabetic%20Cardiac%20Fibroblast:%20Mechanisms%20Underlying%20Phenotype%20and%20Function&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Levick,%20Scott%20P&rft.date=2020-02-01&rft.volume=21&rft.issue=3&rft.spage=970&rft.pages=970-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms21030970&rft_dat=%3Cproquest_doaj_%3E2352048553%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c478t-4306a3918b1f1059f3bab7cc4b4acc106309ea3a5664a0aa189a58ebc34f97853%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2548679479&rft_id=info:pmid/32024054&rfr_iscdi=true